Literature DB >> 29293453

Contribution of activated beta3 integrin in the PDI release from endothelial cells.

Halszka Ponamarczuk1, Marcin Popielarski1, Marta Stasiak1, Radoslaw Bednarek1, Maciej Studzian2, Lukasz Pulaski2, Anna Babinska3, Maria Swiatkowska4.   

Abstract

Protein disulfide isomerase (PDI) is an abundant reticulum endoplasmic protein but also acts as an important functional regulator of some extracellular surface proteins. Recent studies suggest that PDI plays a role in integrin activation and thrombus formation. The aim of this study was to examine whether activation of integrin is the first stage leading to release of PDI from the subcellular compartments of endothelial cells to extracellular space. Our results show that endothelial cells which adhere to fibronectin or fibrinogen release significantly more PDI than those which adhere to poly-L-lysine. Cells treated with RGD peptide, Src and FAK kinase inhibitors and anti alphaVbeta3 antibody display lower PDI secretion. The destruction of the actin cytoskeleton of endothelial cells by cytochalasin D inhibits PDI release. When the endothelial cells adhere to fibrinogen or fibronectin, PDI and alphaVbeta3 gain free thiol groups. Our data suggest that upon activation of integrins, PDI is released from endothelial cells and forms a disulfide bond complex with alphaVbeta3 integrin.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29293453     DOI: 10.2741/4663

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  5 in total

1.  Comparison of anti-cancer effects of novel protein disulphide isomerase (PDI) inhibitors in breast cancer cells characterized by high and low PDIA17 expression.

Authors:  Anna Kurpińska; Joanna Suraj-Prażmowska; Marta Stojak; Joanna Jarosz; Łukasz Mateuszuk; Ewa Niedzielska-Andres; Magdalena Smolik; Joanna Wietrzyk; Ivars Kalvins; Maria Walczak; Stefan Chłopicki
Journal:  Cancer Cell Int       Date:  2022-06-20       Impact factor: 6.429

Review 2.  Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.

Authors:  Corlia Grobler; Siphosethu C Maphumulo; L Mireille Grobbelaar; Jhade C Bredenkamp; Gert J Laubscher; Petrus J Lourens; Janami Steenkamp; Douglas B Kell; Etheresia Pretorius
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

Review 3.  Selective Secretion of KDEL-Bearing Proteins: Mechanisms and Functions.

Authors:  F C Palazzo; R Sitia; T Tempio
Journal:  Front Cell Dev Biol       Date:  2022-07-13

4.  Structural and compositional diversity of fibrillin microfibrils in human tissues.

Authors:  Alexander Eckersley; Kieran T Mellody; Suzanne Pilkington; Christopher E M Griffiths; Rachel E B Watson; Ronan O'Cualain; Clair Baldock; David Knight; Michael J Sherratt
Journal:  J Biol Chem       Date:  2018-02-16       Impact factor: 5.157

5.  Endothelial microparticle-associated protein disulfide isomerase increases platelet activation in diabetic coronary heart disease.

Authors:  Xiao-Di Sun; Lu Han; Hong-Tao Lan; Ran-Ran Qin; Ming Song; Wei Zhang; Ming Zhong; Zhi-Hao Wang
Journal:  Aging (Albany NY)       Date:  2021-07-20       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.